Intravenous Immunoglobulin Market Outlook, Drivers And Industry Analysis 2025

Intravenous immunoglobulin market growth, intravenous immunoglobulin industry insights, intravenous immunoglobulin market demand, intravenous immunoglobulin market drivers, intravenous immunoglobulin market outlook, intravenous immunoglobulin market size
What Are The Predictions For The Intravenous Immunoglobulin Market Size And Growth Rate?
The intravenous immunoglobulin market has showcased robust growth in recent years, escalating from $14.66 billion in 2024 to a projected $15.72 billion by 2025, at an impressive compound annual growth rate (CAGR) of 7.2%. This historic period witnessed growth influenced by aspects such as treatment of primary immunodeficiency disorders, management of neurological disorders, an increase in the aging population, and advancements in plasma fractionation techniques.
For the forthcoming years, the market is expected to have an unparalleled growth to $22.01 billion by 2029, maintaining the momentum with a CAGR of 8.8%. Factors like increasing prevalence of autoimmune disorders, ongoing research in immunology, growing healthcare expenditure, rise in cancer incidence, innovation in immunoglobulin products, and the emerging personalized medicine approach have substantially contributed to the forecasted growth.
Get Your Free Sample of The Global Intravenous Immunoglobulin Market Report:
What Is Driving The Intravenous Immunoglobulin Market Growth?
The intravenous immunoglobulin market is strongly driven by the increasing geriatric population. People above the age of 65, due to their weakened immunity and a lack of antibodies, require immunoglobulins which consequentially increases the demand for intravenous immunoglobulins. A vivid instance is the prediction made by the Population Reference Bureau, a Kenya-based nonprofit organization, which foresees the American population above 65 years of age increasing from 58 million in 2022 to 82 million by 2050, a 47% surge. This bolstered growth in the geriatric population will inevitably drive the intravenous immunoglobulin market forward.
Which Segments Dominate The Intravenous Immunoglobulin Market?
The intravenous immunoglobulin market is divided into numerous segments:
1) By Type: Immunoglobulin G (IgG), Immunoglobulin M (IgM), Immunoglobulin A (IgA), Immunoglobulin E (IgE), Immunoglobulin D (IgD)
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications
4) By End-User: Hospitals, Clinics, Home Care
Which Are The Major Players In The Intravenous Immunoglobulin Market?
Renowned companies operating in the intravenous immunoglobulin market include Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., among others.
What Trends Are Influencing The Intravenous Immunoglobulin Market?
Trends steering the intravenous immunoglobulin market include the focus on product innovation such as liquid immune globulin formulations for the treatment of immunodeficiency diseases by major companies to maintain market prominence. For instance, in December 2023, GC Pharma, a South Korea-based pharmaceutical company, launched Alyglo, an FDA-approved medication made of liquid formulation containing 10% immunoglobulin G (IgG) for treating primary humoral immunodeficiency (PI) in adults aged over 17 years.
Which Region Will Witness The Fastest Growth In The Intravenous Immunoglobulin Market?
In 2024, North America dominated the intravenous immunoglobulin market as the largest region. The upcoming periods project Asia-Pacific as the fastest-growing region.
What Does The Intravenous Immunoglobulin Market Report 2025 Offer?
The Intravenous Immunoglobulin Market research report presents a comprehensive study of the global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities. The report definition of intravenous immunoglobulin relates to a therapeutic method utilized in treating immunodeficient people. The process employs an intravenous infusion of a sterile, purified liquid made from immunoglobulins collected from healthy individuals.
Purchase the exclusive report now to unlock valuable market insights: 
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8538
About The Business Research Company
With more than 15000+ reports across 27 industries and covering 60+ geographies, The Business Research Company has built a reputation for delivering comprehensive and data-rich research and insights. Equipped with over 1,500,000 datasets, backed by the power of in-depth secondary research, and unique insights from industry leaders, we provide the information you need to stay ahead.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Follow Us On:

Leave a Reply

Your email address will not be published. Required fields are marked *